Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095654
Status:
COMPLETED
Last Update Posted:
2009-11-10
First Post:
2004-11-05
Brief Title:
The DREAM Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication Trial
Sponsor:
Gerstein Hertzel MD
Organization:
Gerstein Hertzel MD
Organization Data
Organization:
Gerstein Hertzel MD
Class:
INDIV
Study ID:
DREAM30Nov2002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gerstein Hertzel MD
Lead Sponsor Class:
INDIV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | INDUSTRY |
| Canadian Institutes of Health Research CIHR | OTHER_GOV |
| Aventis Pharmaceuticals | INDUSTRY |
| GlaxoSmithKline | INDUSTRY |
| King Pharmaceuticals is now a wholly owned subsidiary of Pfizer | INDUSTRY |